Jonathan A. Leon Sells 5,282 Shares of Owens & Minor, Inc. (NYSE:OMI) Stock

Owens & Minor, Inc. (NYSE:OMI) CFO Jonathan A. Leon sold 5,282 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares of the company’s stock, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Owens & Minor Trading Up 0.9 %

Shares of OMI opened at $13.31 on Thursday. Owens & Minor, Inc. has a 1-year low of $11.42 and a 1-year high of $28.35. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The firm has a 50 day simple moving average of $13.65 and a 200-day simple moving average of $15.09. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of -20.48, a price-to-earnings-growth ratio of 0.47 and a beta of 0.41.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same quarter last year, the business posted $0.44 earnings per share. Owens & Minor’s revenue was up 5.0% compared to the same quarter last year. Equities analysts forecast that Owens & Minor, Inc. will post 1.49 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Owens & Minor by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock worth $242,459,000 after acquiring an additional 162,182 shares during the period. Royce & Associates LP boosted its stake in Owens & Minor by 179.4% in the 3rd quarter. Royce & Associates LP now owns 80,914 shares of the company’s stock worth $1,270,000 after buying an additional 51,955 shares during the last quarter. Deerfield Management Company L.P. Series C increased its stake in shares of Owens & Minor by 30.6% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock valued at $86,014,000 after acquiring an additional 1,493,852 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Owens & Minor by 16.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock worth $16,829,000 after acquiring an additional 176,250 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in shares of Owens & Minor by 1.7% in the second quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company’s stock worth $61,213,000 after acquiring an additional 76,599 shares during the last quarter. 98.04% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on OMI. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. Barclays decreased their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. JPMorgan Chase & Co. dropped their target price on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a report on Wednesday, August 21st. Robert W. Baird decreased their price target on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Finally, UBS Group dropped their price objective on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research note on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $18.50.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.